l8ee3t4w | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Lucio_Liberato%2C_Nicola%3B_De_Monte%2C_Andrea%3B_Caravella%2C_Giuseppe>
?:doi	<https://research.tib.eu/covid-19/entity/10.5114/aoms.2020.97411>
?:doi	10.5114/aoms.2020.97411
?:journal	Arch_Med_Sci
?:license	cc-by-nc-sa
?:pdf_json_files	document_parses/pdf_json/871f8a6fa1307cb4e6da6e34d2b53cf805c12843.json
?:pmc_json_files	document_parses/pmc_json/PMC7667418.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7667418>
?:pmid	<https://research.tib.eu/covid-19/entity/33224347.0>
?:pmid	33224347.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/l8ee3t4w_HAS_C1609165_ASSOCIATED_WITH_C5203670>
?:sha_id	<https://research.tib.eu/covid-19/entity/871f8a6fa1307cb4e6da6e34d2b53cf805c12843>
?:source	Medline; PMC
?:title	Tocilizumab in severe COVID-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-07-16

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/l8ee3t4w>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/l8ee3t4w>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all